Tags: lung cancer

ProLung, Inc., a Salt Lake City-based business focused on making a difference in time for lung cancer patients with its innovative predictive analytics technology and non-invasive tests for the risk stratification of indeterminate pulmonary nodules, annou ...

ProLung, Inc., which is focused on making a difference in time for lung cancer patients with its innovative predictive analytics technology and non-invasive tests for the risk stratification of indeterminate pulmonary nodules, announces the appointment of ...

ProLung, Inc., the world leader in innovative predictive analytics technology and non-invasive tests for the risk stratification of lung cancer, announces today the appointment of Kristin M. Larson, NP, to Director of Clinical Affairs. Steven C. Eror, Pre ...